M

Marinomed Biotech AG
VSE:MARI

Watchlist Manager
Marinomed Biotech AG
VSE:MARI
Watchlist
Price: 19.25 EUR Market Closed
Market Cap: 35.4m EUR

Operating Margin
Marinomed Biotech AG

112.1%
Current
-44%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
112.1%
=
Operating Profit
13.4m
/
Revenue
11.9m

Operating Margin Across Competitors

No Stocks Found

Marinomed Biotech AG
Glance View

Market Cap
34.2m EUR
Industry
Pharmaceuticals

Marinomed Biotech AG is a biopharmaceutical company, which engages in the development of therapies based on patent protected technology platforms. The company is headquartered in Korneuburg, Niederoesterreich and currently employs 43 full-time employees. The company went IPO on 2019-02-01. The firm develops antiviral and immunological therapies such as nasal sprays using the respiratory disease antiviral technology platform, Marinosolv and the Carragelose platform. With the Marinosolv technology platform, it is possible to improve the effectiveness of poorly soluble active ingredients. This technology has the potential to change some therapies in the field of allergy and autoimmune diseases. The Carragelose platform is already used in six different products against viral infections of the respiratory tract. The firm also offers products for the treatment of influenza, combination products for asthmatics, and others. The firm also develops treatments for type I allergies and autoimmune diseases. The firm is a spin-off from the University of Veterinary Medicine, Vienna.

MARI Intrinsic Value
26.54 EUR
Undervaluation 27%
Intrinsic Value
Price
M
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
112.1%
=
Operating Profit
13.4m
/
Revenue
11.9m
What is the Operating Margin of Marinomed Biotech AG?

Based on Marinomed Biotech AG's most recent financial statements, the company has Operating Margin of 112.1%.

Back to Top